FIM
ONC icon

Foresters Investment Management’s BeOne Medicines Ltd ONC Stock Holding History

Foresters Investment Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,232
Closed -$120K – 585
2017
Q4 		$120K Buy
1,232
+1,056
+600% +$96.7K ﹤0.01% 550
2017
Q3 		$18K Buy
+176
New +$13.1K ﹤0.01% 589

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Foresters Investment Management's ONC Position: Q1 2018 in Review

Foresters Investment Management sold out of BeOne Medicines Ltd (ONC) in Q1 2018, closing a stake of 1,232 shares — an estimated $120K sold.

Foresters Investment Management first reported a position in ONC in Q3 2017 and held it in 2 quarters. The position peaked at $120K in Q4 2017. 123 funds tracked by Wall St. Rank hold ONC as of Q1 2018.

  • Foresters Investment Management reported no remaining BeOne Medicines Ltd position as of Q1 2018 after selling out during the quarter.
  • Foresters Investment Management sold 1,232 BeOne Medicines Ltd shares in Q1 2018, an estimated $120K.
  • Foresters Investment Management first reported a position in BeOne Medicines Ltd in Q3 2017 and held it in 2 quarters.
  • Foresters Investment Management's BeOne Medicines Ltd position peaked at $120K in Q4 2017.
  • 123 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2018.

Based on Foresters Investment Management's 13F filing for Q1 2018, filed 11 May 2018.